Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi‐based consensus-Reference-Cited by-同舟云学术

Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi‐based consensus

Published:2021-04-27 Issue:3 Volume:185 Page:616-626
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Brüggen M.‐C.¹²³⁴^ORCID,Le S.T.⁵,Walsh S.⁴⁶,Toussi A.⁵,Prost N.⁷⁸,Ranki A.⁴⁹,Didona B.⁴¹⁰,Colin A.⁴⁸¹¹,Horváth B.⁴¹²,Brezinova E.⁴¹³,Milpied B.⁴⁸¹⁴,Moss C.⁴¹⁵,Bodemer C.⁴⁸¹⁶,Meyersburg D.⁴¹⁷,Salavastru C.⁴¹⁸,Tiplica G.‐S.⁴¹⁹,Howard E.⁴¹⁵,Bequignon E.⁴²⁰,Bouwes Bavinck J.N.²¹,Newman J.²²,Gueudry J.⁸²³,Nägeli M.¹,Zaghbib K.⁸²⁴,Pallesen K.⁴²⁵,Bygum A.⁴²⁶,Joly P.⁴⁸²⁷,Wolkenstein P.⁴⁸¹¹,Chua S.‐L.⁴²⁸,Le Floch R.⁸²⁹,Shear N.H.³⁰³¹,Chu C.‐Y.³²,Hama N.³³,Abe R.³³,Chung W.‐H.³⁴,Shiohara T.³⁵,Ardern‐Jones M.³⁶,Romanelli P.³⁷,Phillips E.J.³⁸,Stern R.S.³⁹,Cotliar J.⁴⁰,Micheletti R.G.⁴¹,Brassard A.⁵,Schulz J.T.⁴²,Dodiuk‐Gad R.P.³¹,Dominguez A.R.⁴³,Paller A.S.⁴⁴,Seminario‐Vidal L.⁴⁵,Mostaghimi A.⁴⁶,Noe M.H.⁴⁶,Worswick S.⁴⁷,Tartar D.⁵,Sheridan R.⁴⁸,Kaffenberger B.H.⁴⁹,Shinkai K.⁵⁰,Maverakis E.⁵,French L.E.⁴³⁶⁵¹,Ingen‐Housz‐Oro S.⁴⁸¹¹⁵²^ORCID

Affiliation:

1. Department of Dermatology University Hospital Zurich Zurich Switzerland

2. Faculty of Medicine University of Zurich Zurich Switzerland

3. Christine Kühne Center for Allergy Research and Education Davos Switzerland

4. ToxiTEN Group European Reference Network for Rare Skin Diseases (ERN‐skin) Paris France

5. Department of Dermatology University of California Davis, Sacramento CA USA

6. Department of Dermatology King’s College Hospital LondonUK

7. Intensive Care Unit AP‐HP Henri Mondor Hospital CréteilFrance

8. Toxic Bullous Dermatoses TOXIBUL Reference Centre Filière FIMARAD AP‐HP Henri Mondor Hospital CréteilFrance

9. Department of Skin and Allergic Diseases University of Helsinki and Helsinki University Central Hospital HelsinkiFinland

10. First Dermatology Division Institute Dermopatico dell’Immacolata (I.D.I.) – IRCCS Via Monti di Creta 104 Rome 00167Italy

11. Dermatology Department AP‐HP, Henri Mondor Hospital CréteilFrance

12. Department of Dermatology, Center for Blistering Diseases University Medical Center Groningen, University of Groningen Groningenthe Netherlands

13. Department of Dermatovenereology St Ann’s University Hospital Faculty of Medicine Masaryk University BrnoCzech Republic

14. Department of Dermatology CHU Bordeaux BordeauxFrance

15. Birmingham Children’s Hospital and University of Birmingham BirminghamUK

16. Department of Dermatology AP‐HP Necker Hospital ParisFrance

17. Department of Dermatology and Allergology University Hospital Salzburg of the Paracelsus Medical University Salzburg SalzburgAustria

18. Department of Paediatric Dermatology Colentina Clinical Hospital Carol Davila University of Medicine and Pharmacy BucharestRomania

19. Department of Dermatology II Colentina Clinical Hospital Carol Davila University of Medicine and Pharmacy BucharestRomania

20. Department of Otorhinolaryngology and Head and Neck Surgery AP‐HP Henri Mondor Hospital CréteilFrance

21. Department of Dermatology Leiden University Medical Center Leidenthe Netherlands

22. Macmillan Skin Cancer CNS Normanby BuildingDenmark Hill LondonUK

23. Ophthalmology Department Hospital Charles Nicolle, EA7510, UFR Santé, Rouen University RouenFrance

24. Department of Psychiatry AP‐HP, Henri Mondor‐Albert Chenevier Hospitals CrFrance

25. Department of Dermatology Aarhus University Hospital Palle Juul‐Jensens AarhusDenmark

26. Clinical Institute, University of Southern Denmark, Department of Clinical Genetics, Odense University Hospital OdenseDenmark

27. Department of Dermatology CHU Charles Nicolle, RouenFrance

28. Queen Elizabeth Hospital Birmingham University Hospital Birmingham NHS Foundation Trust BirminghamUK

29. Réanimation Chirurgicale et des Brûlés PTMC, CHU Nantes NantesFrance

30. Division of Clinical Pharmacology and Toxicology University of Toronto Toronto ONCanada

31. Division of Dermatology Sunnybrook Health Sciences Centre Toronto ONCanada

32. Department of Dermatology National Taiwan University Hospital and National Taiwan University College of Medicine TaipeiTaiwan

33. Niigata University Graduate School of Medical and Dental Sciences NiigataJapan

34. Department of Dermatology, Drug Hypersensitivity Clinical and Research Center Chang Gung Memorial Hospital TaoyuanTaiwan

35. Department of Dermatology Kyorin University School of Medicine TokyoJapan

36. Clinical Experimental Sciences, Faculty of Medicine University of Southampton SouthamptonUK

37. Department of Dermatology and Cutaneous Surgery, Miller School of Medicine University of Miami Miami FLUSA

38. Department of Medicine & Pharmacology Vanderbilt University Medical Center Nashville TNUSA

39. Beth Israel Deaconess Medical Center, Harvard Medical School Boston MAUSA

40. Science 37 Los Angeles CAUSA

41. Department of Dermatology, Perelman School of Medicine University of Pennsylvania Philadelphia PAUSA

42. Massachusetts General Hospital, Harvard Medical School Boston MAUSA

43. Department of Dermatology, Department of Internal Medicine University of Texas Southwestern Medical Center Dallas TXUSA

44. Departments of Dermatology and Pediatrics Northwestern University Feinberg School of Medicine Chicago ILUSA

45. Department of Dermatology University of South Florida, Cutaneous Oncology Program, Moffitt Cancer Center Tampa FLUSA

46. Department of Dermatology, Brigham & Women’s Hospital Harvard Medical School Boston MAUSA

47. Keck‐USC School of Medicine Los Angeles CAUSA

48. Burn Surgery Service Shriners Burns Hospital Sumner Redstone Burn Center Massachusetts General Hospital Harvard Medical School Boston MAUSA

49. Division of Dermatology Department of Internal Medicine Ohio State University Columbus OHUSA

50. Department of Dermatology University of California San Francisco CAUSA

51. Department of Dermatology and Allergy University Hospital of Munich LMU MunichGermany

52. Universit EpiDermE CréteilFrance

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19893

Reference44 articles.

1. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)

2. Severe cutaneous adverse reactions to drugs

3. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

4. Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

5. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management;Journal of the European Academy of Dermatology and Venereology;2024-07-18

2. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12

3. Management of pain in the inpatient and non-surgical outpatient dermatology settings: A narrative review;Indian Journal of Dermatology, Venereology and Leprology;2024-06-12

4. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

5. A retrospective analysis of mortality risk and immunosuppressive therapy for Stevens-Johnson Syndrome and toxic epidermal necrolysis syndrome using the TriNetX research network;Burns;2024-02